S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?

SI-BONE Stock Price, News & Analysis (NASDAQ:SIBN)

$17.80
-0.50 (-2.73%)
(As of 12/6/2023 ET)
Compare
Today's Range
$17.46
▼
$18.49
50-Day Range
$15.75
▼
$21.39
52-Week Range
$11.23
▼
$29.51
Volume
399,193 shs
Average Volume
353,643 shs
Market Capitalization
$720.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.17
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability

SI-BONE MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
52.6% Upside
$27.17 Price Target
Short Interest
Healthy
2.30% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
0.27mentions of SI-BONE in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$761,439 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.14) to ($0.97) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Medical Sector

421st out of 957 stocks

Surgical & Medical Instruments Industry

44th out of 78 stocks

See Top Rated MarketRank™ Stocks Here

SIBN stock logo

About SI-BONE Stock (NASDAQ:SIBN)

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and distributors. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SIBN Stock Price History

SIBN Stock News Headlines

December 6, 2023 | americanbankingnews.com
SI-BONE (NASDAQ:SIBN) Stock Rating Reaffirmed by Needham & Company LLC
December 5, 2023 | markets.businessinsider.com
SI-Bone: Strong Fundamentals and Impending Profitability Underpin Buy Rating
December 7, 2023 | Financial Alphas (Ad)
Lithium Discovery So BIG You Can't Miss it, Even From Space
With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!
December 4, 2023 | benzinga.com
SI-BONE Stock (NASDAQ:SIBN), Analyst Ratings, Price Targets, Predictions
November 30, 2023 | benzinga.com
SI-BONE Stock (NASDAQ:SIBN) Dividends: History, Yield and Dates
November 30, 2023 | finance.yahoo.com
Si-Bone (SIBN) Crossed Above the 50-Day Moving Average: What That Means for Investors
November 23, 2023 | morningstar.com
SI-BONE Inc SIBN
November 21, 2023 | finance.yahoo.com
Insider Sell: President, Commercial Ops Anthony Recupero Sells 8,457 Shares of SI-BONE Inc (SIBN)
December 7, 2023 | Edge On The Street (Ad)
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
November 16, 2023 | seekingalpha.com
Sizing Up SI-BONE After Q3 Earnings
November 14, 2023 | finance.yahoo.com
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
November 7, 2023 | markets.businessinsider.com
Cantor Fitzgerald Maintains Overweight Rating for SI-BONE: Here's What You Need To Know
November 7, 2023 | finance.yahoo.com
SI-BONE, Inc. (NASDAQ:SIBN) Q3 2023 Earnings Call Transcript
November 6, 2023 | msn.com
SI-BONE GAAP EPS of -$0.25 beats by $0.09, revenue of $34M beats by $1.62M
November 6, 2023 | finance.yahoo.com
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
November 6, 2023 | finance.yahoo.com
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
November 6, 2023 | finance.yahoo.com
SI-BONE Inc (SIBN) Reports Record Q3 2023 Financial Results, Raises Annual Guidance
November 5, 2023 | finance.yahoo.com
The past three years for SI-BONE (NASDAQ:SIBN) investors has not been profitable
November 5, 2023 | markets.businessinsider.com
SI-BONE earnings preview: what Wall Street is expecting
November 1, 2023 | finance.yahoo.com
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
October 16, 2023 | finance.yahoo.com
SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
October 9, 2023 | finance.yahoo.com
Si-Bone (SIBN) Upgraded to Buy: Here's Why
September 8, 2023 | finance.yahoo.com
Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?
September 6, 2023 | finance.yahoo.com
Does Si-Bone (SIBN) Have the Potential to Rally 39.93% as Wall Street Analysts Expect?
September 5, 2023 | finance.yahoo.com
SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods
August 31, 2023 | msn.com
SI-BONE: Another Record Quarter, Reinvesting For Future Growth, Reiterate Buy
August 29, 2023 | finance.yahoo.com
SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023
See More Headlines
Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/26/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SIBN
CUSIP
N/A
CIK
1459839
Web
www.si-bone.com
Phone
(408) 207-0700
Fax
N/A
Employees
357
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$27.17
High Stock Price Target
$33.00
Low Stock Price Target
$24.00
Potential Upside/Downside
+52.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-61,260,000.00
Net Margins
-32.98%
Pretax Margin
-32.98%
Return on Equity
-32.05%
Return on Assets
-22.57%

Debt

Debt-to-Equity Ratio
0.21
Current Ratio
10.89
Quick Ratio
9.74

Sales & Book Value

Annual Sales
$106.41 million
Price / Sales
6.77
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.85 per share
Price / Book
6.25

Miscellaneous

Outstanding Shares
40,500,000
Free Float
38,314,000
Market Cap
$720.90 million
Optionable
Not Optionable
Beta
1.01

Social Links

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions














SIBN Stock Analysis - Frequently Asked Questions

Should I buy or sell SI-BONE stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-BONE in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SIBN shares.
View SIBN analyst ratings or view top-rated stocks.

What is SI-BONE's stock price target for 2024?

5 analysts have issued 1 year price targets for SI-BONE's shares. Their SIBN share price targets range from $24.00 to $33.00. On average, they expect the company's stock price to reach $27.17 in the next twelve months. This suggests a possible upside of 52.6% from the stock's current price.
View analysts price targets for SIBN or view top-rated stocks among Wall Street analysts.

How have SIBN shares performed in 2023?

SI-BONE's stock was trading at $13.60 on January 1st, 2023. Since then, SIBN stock has increased by 30.9% and is now trading at $17.80.
View the best growth stocks for 2023 here.

When is SI-BONE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024.
View our SIBN earnings forecast.

How were SI-BONE's earnings last quarter?

SI-BONE, Inc. (NASDAQ:SIBN) issued its quarterly earnings results on Monday, November, 6th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.08. The company had revenue of $34.01 million for the quarter, compared to analysts' expectations of $32.23 million. SI-BONE had a negative trailing twelve-month return on equity of 32.05% and a negative net margin of 32.98%.

What is Jeffrey Dunn's approval rating as SI-BONE's CEO?

10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of SI-BONE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-BONE investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), RTX (RTX), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO) and CSX (CSX).

When did SI-BONE IPO?

(SIBN) raised $84 million in an initial public offering on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who are SI-BONE's major shareholders?

SI-BONE's stock is owned by a variety of institutional and retail investors. Top institutional investors include Brown Advisory Inc. (10.32%), Morgan Stanley (2.00%), Allspring Global Investments Holdings LLC (1.75%), Wellington Management Group LLP (1.50%), Impax Asset Management Group plc (1.23%) and Paradigm Capital Management Inc. NY (0.96%). Insiders that own company stock include Anshul Maheshwari, Anthony J Recupero, Anthony J Recupero, Gregory K Hinckley, Jeffrey W Dunn, Jeffrey W Dunn, Jeryl L Hilleman, Jeryl L Hilleman, John Gordon Freund, Laura Francis, Michael A Pisetsky and Michael A Pisetsky.
View institutional ownership trends.

How do I buy shares of SI-BONE?

Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does SI-BONE have any subsidiaries?
The following companies are subsidiares of SI-BONE: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD.
Read More
This page (NASDAQ:SIBN) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -